Summary
ADRUG development company that is working to combat MRSA and cancer has said its products are almost ready to go to market and that it expects to exceed its previous target of becoming a pounds 100m business.
Newcastle firm e-Therapeutics is poised for expansion, despite yesterday posting a small drop in its losses from pounds 2.2m to pounds 1.9m, as it gears up for the launch of its three main drugs, an anti-depressant, an oral asthma drug and an antibiotic for the Indian market, which are to be launched in 2011.See the full content of this document
Extract
Drug Development Firm Expects to Exceed Target
It is developing the drugs working with Mumbai-based company Khandelwal Laboratories, and is now poised to begin clinical tr...
See the full content of this document
Sponsored links
